This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC. Active years: 2018-2026.
Company Filing History:
Years Active: 2018-2026
Title: Narayan Variankaval: Innovator in Pharmaceutical Formulations
Introduction
Narayan Variankaval is a notable inventor based in Plainsboro, NJ (US), recognized for his contributions to pharmaceutical formulations. With a total of three patents to his name, he has made significant strides in the field of drug development.
Latest Patents
Among his latest patents is a solid dosage formulation of an orexin receptor antagonist. This invention is directed to a pharmaceutical composition comprising the compound suvorexant, or a pharmaceutically acceptable salt thereof, along with a concentration-enhancing polymer and, optionally, a pharmaceutically acceptable surfactant. This innovative approach aims to improve the efficacy and delivery of the medication.
Career Highlights
Narayan Variankaval is currently associated with Merck Sharp & Dohme Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective drug formulations that can enhance patient outcomes.
Collaborations
He has collaborated with esteemed colleagues such as Paul A Harmon and Michael Lowinger, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Narayan Variankaval's work in pharmaceutical formulations exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and the healthcare industry.